International Journal of Drug Policy
Volume 14, Issue 5 , Pages 353-357 , December 2003

Effectiveness of needle and syringe programmes for preventing HIV transmission

  • Margaret MacDonald

      Affiliations

    • National Centre in HIV Epidemiology and Clinical Research, University of NSW Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia
    • Corresponding Author InformationCorresponding author. Fax: +61-2-9332-1837.
    • ,
  • Matthew Law

      Affiliations

    • National Centre in HIV Epidemiology and Clinical Research, University of NSW Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia
    • ,
  • John Kaldor

      Affiliations

    • National Centre in HIV Epidemiology and Clinical Research, University of NSW Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia
    • ,
  • Jim Hales

      Affiliations

    • Health Outcomes International Pty. Ltd., P.O. Box 1038, Kent Town, SA 5071, Australia
    • Fax: +61-8-8363-9011.
    • ,
  • Gregory J. Dore

      Affiliations

    • National Centre in HIV Epidemiology and Clinical Research, University of NSW Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia

Received 1 December 2002 ,Revised 15 March 2003 ,Accepted 2 July 2003.

References 

  1. Bruneau J, Lamothe F, Franco E. High rates of HIV infection among injecting drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 1997;145:994–1002
  2. Des Jarlais DC, Hagan HR, Friedman SR, et al.  Maintaining low HIV seroprevalences in populations of injecting drug users. The Journal of the American Medical Association. 1995;274:1226–1231
  3. Des Jarlais DC, Marmor M, Paone D, et al.  HIV incidence among injecting drug users in New York City syringe-exchange programs. Lancet. 1996;348:987–991
  4. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(Suppl. A):S217–S230
  5. Fischer B, Rehm J, Blitz-Miller T. Injection drug use and preventative measures: A comparison of Canadian and Western European jurisdictions over time. Canadian Medical Association Journal. 2000;162:1709–1713
  6. Hagen H, McGough JP, Thiede H, et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology. 1999;149:203–213
  7. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989–1990. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;15(2):157–164
  8. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797–1800
  9. Miller CL, Tyndall M, Spittal P, Li K, Palepu A, et al.  Risk-taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health. 2002;79(2):257–265
  10. US Census Bureau UNAIDS Collaborating Centre. (2000). HIV/AIDS Surveillance Data Base. Health Studies Branch, International Programs Center, Population Division, U.S. Census Bureau, Washington.
  11. Van Ameijden EJC, Van den Hoek JAR, Mientjes GHC, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology. 1993;9:225–262

PII: S0955-3959(03)00133-6

doi: 10.1016/S0955-3959(03)00133-6

International Journal of Drug Policy
Volume 14, Issue 5 , Pages 353-357 , December 2003

Article Tools

* Image Usage & Resolution